• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about FDA Approval

Recent news which mentions FDA Approval

FDA Bans Vuse Menthol E-Cigs: Why Some Vapes Like Elf Bars Avoid Scrutiny, Others Don't
October 13, 2023
Tickers BTI MO NFLX
Tags China MO Benzinga
From Benzinga
PharmaTher Holdings Nabs New Orphan Drug Status, Discusses Further Fast-Track, Partners For MDMA Patch
February 03, 2023
Tickers PHRRF RVVTF
Tags Market News FDA Approval News
From Benzinga
Bulls In A Bear Market: These 10 Stocks Clocked Gains In Excess Of 100% In 2022
December 31, 2022
Tickers AAPL ADMA AMPY ARDX
Tags Analyst Color kidney disease News
From Benzinga
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
December 27, 2022
Tickers BGNE BIIB CDTX CHRS
Tags CDTX REGN News
From Benzinga
Spectrum Gets FDA Nod For Febrile Neutropenia Candidate, Sees Commercial Launch In Q4 2022
September 09, 2022
Tickers SPPI
Tags News Health Care Market News
From Benzinga
Revance Shares Shoot Higher As FDA Cleared DAXXIFY Injection For Frown Lines
September 08, 2022
Tickers RVNC
Tags General Biotech FDA
From Benzinga
Sanofi's Rare Disease Drug Xenpozyme Scores FDA Approval
September 01, 2022
Tickers SNY
Tags General SNY Benzinga
From Benzinga
Incyte Gets FDA Nod For Hematologic Malignancies Candidate
August 26, 2022
Tickers INCY
Tags Market News FDA Approval News
From Benzinga
Axsome Shares Shoot Higher As FDA Approves Major Depressive Disorder Candidate
August 19, 2022
Tickers AXSM
Tags Market News AXSM FDA Approval
From Benzinga
Bluebird Secures FDA Nod For Genetic Blood Disease Candidate
August 17, 2022
Tickers BLUE
Tags Market News BLUE FDA Approval
From Benzinga
Arcutis Gets FDA Nod For Plaque Psoriasis Candidate, Sees Commercial Launch In Mid-August
July 29, 2022
Tickers ARQT
Tags Market News FDA Approval News
From Benzinga
Horizon Therapeutics Receives FDA Approval For Uncontrolled Gout Candidate
July 08, 2022
Tickers HZNP
Tags FDA Biotech Benzinga
From Benzinga
FDA Green Lights Ceruvia's Phase 2 Psilocybin Trial Program For Obsessive-Compulsive Disorder Treatment
June 29, 2022
Tags Carey Turnbull Cannabis Markets
From Benzinga
Cybin's Psilocybin Analog CYB003 Gets FDA Clearance For Trial To Potentially Treat Major Depressive Disorder
June 28, 2022
Tickers CYBN
Tags Benzinga CYBN Markets
From Benzinga
Rhythm Pharmaceuticals' Shares Dive Following FDA's Verdict On IMCIVREE Drug
June 16, 2022
Tickers RYTM
Tags General FDA Biotech
From Benzinga
U.S. FDA Approves Regeneron And Sanofi's Lead Drug For Skin Inflammation In Children
June 07, 2022
Tickers REGN SNY
Tags SNY General FDA
From Benzinga
Major Depressive Disorder Could Soon Have Treatment Option Via Cybin's Psilocybin Analog
May 31, 2022
Tickers CYBN
Tags Topics Psychology Psychedelics
From Benzinga
High Hopes For Alcohol Use Disorder Treatment: Clearmind's Successful Pre-IND Meeting With The FDA
May 26, 2022
Tickers CMNDF
Tags alcohol use disorder Psychology Psychedelics
From Benzinga
Psychedelics Biotech Companies Mark New Milestones In Drug Development Pipelines: Field Trip, Cybin and Wesana
January 11, 2022
Tickers CYBN FTRP WSNAF
Tags FTRP WSNAF Penny Stocks
From Benzinga
Boston Scientific's Exalt Model B Single-Use Bronchoscope Wins FDA Approval
August 11, 2021
Tickers BSX
Tags Health Care News FDA Approval
From Benzinga
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap